Alyeska Investment Group, L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$21,398,000
-10.4%
775,299
-41.3%
0.18%
-6.8%
Q4 2017$23,891,000
+96.0%
1,319,945
+74.9%
0.19%
+108.8%
Q3 2017$12,188,000
+27.6%
754,657
+9.5%
0.09%
+13.8%
Q2 2017$9,548,000
-20.1%
689,397
-13.4%
0.08%
-17.5%
Q1 2017$11,945,000
+74.2%
796,331
+52.1%
0.10%
+70.2%
Q4 2016$6,859,000
+102.7%
523,597
+166.7%
0.06%
+83.9%
Q3 2016$3,383,000
+48.8%
196,342
+25.6%
0.03%
-3.1%
Q1 2015$2,274,000
+31.7%
156,268
-8.9%
0.03%
+10.3%
Q4 2014$1,726,000
+64.9%
171,554
+36.5%
0.03%
+31.8%
Q3 2014$1,047,000125,6690.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders